• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Recent Advances in the Study of 5-amino-N,2-dimethylbenzenesulfonamide (CAS: 6274-17-5): A Comprehensive Research Brief

5-amino-N,2-dimethylbenzenesulfonamide (CAS: 6274-17-5) is a sulfonamide derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive compounds, particularly in the development of antimicrobial and anticancer agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug discovery.

One of the most notable advancements in the study of 5-amino-N,2-dimethylbenzenesulfonamide is its application in the design of sulfonamide-based inhibitors targeting carbonic anhydrase (CA) isoforms. Researchers have demonstrated that modifications to the sulfonamide scaffold, including the introduction of the amino and dimethyl groups, can significantly enhance the selectivity and potency of these inhibitors. A 2023 study published in the Journal of Medicinal Chemistry reported that derivatives of 5-amino-N,2-dimethylbenzenesulfonamide exhibited nanomolar affinity for CA IX, a tumor-associated isoform, suggesting its potential as a lead compound for anticancer therapy.

In addition to its role in CA inhibition, 5-amino-N,2-dimethylbenzenesulfonamide has been investigated for its antimicrobial properties. A recent Bioorganic & Medicinal Chemistry Letters article highlighted its efficacy against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The study attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism distinct from traditional sulfonamide antibiotics. These findings underscore the potential of 5-amino-N,2-dimethylbenzenesulfonamide as a scaffold for developing next-generation antimicrobial agents.

From a synthetic chemistry perspective, advancements in the scalable production of 5-amino-N,2-dimethylbenzenesulfonamide have also been reported. A 2022 Organic Process Research & Development paper detailed an optimized, green chemistry-based synthesis route that minimizes hazardous byproducts and improves yield. This development is critical for facilitating large-scale production and further pharmacological evaluation of the compound and its derivatives.

Despite these promising results, challenges remain in the clinical translation of 5-amino-N,2-dimethylbenzenesulfonamide-based therapeutics. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through rigorous preclinical studies. However, the compound's versatility and demonstrated biological activities make it a compelling candidate for continued research. Future directions may include structure-activity relationship (SAR) studies to optimize its pharmacological profile and the exploration of its applications in other therapeutic areas, such as neurology and inflammation.

In conclusion, 5-amino-N,2-dimethylbenzenesulfonamide (CAS: 6274-17-5) represents a promising scaffold in medicinal chemistry, with recent studies highlighting its potential in anticancer and antimicrobial drug development. Ongoing research efforts are expected to further elucidate its mechanisms of action and expand its therapeutic applications, solidifying its role as a valuable tool in the fight against disease.

• 79-72-1(5-Amino-2-methyl-N-phenylbenzenesulfonamide)
• 6973-09-7(5-amino-2-methylbenzene-1-sulfonamide)
• 25116-87-4(Benzenesulfonamide,2,4,6-trimethyl-N-phenyl-)
• 13440-22-7(Benzenesulfonamide,N,2-dimethyl-)
• 6326-21-2(N,2,5-trimethylbenzene-1-sulfonamide)
• 83763-51-3(4-Amino-N-(p-tolyl)toluene-2-sulphonamide)
• 6331-67-5(5-amino-N,N,2-trimethylbenzene-1-sulfonamide)
• 56776-55-7(2-methyl-N-phenyl-benzenesulfonamide)
• 1025088-44-1(Benzenesulfonamide,5-amino-N-(4-aminophenyl)-2-methyl-)
• 143182-20-1(1,3-Benzenedisulfonamide,4,6-dimethyl-N1,N3-diphenyl-)